- Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ estimates
Noticias del mercado
17 octubre 2017
Company News: Johnson & Johnson (JNJ) quarterly results beat analysts’ estimates
Johnson & Johnson (JNJ) reported Q3 FY 2017 earnings of $1.90 per share (versus $1.68 in Q3 FY 2016), beating analysts' consensus estimate of $1.80.
The company's quarterly revenues amounted to $19.650 bln (+10.3% y/y), beating analysts' consensus estimate of $19.291 bln.
The company also raised FY2017 EPS guidance to $7.25-7.30 from $7.12-7.22 (versus analysts' consensus estimate of $7.18) and FY2017 revenues forecast to $76.1-76.5 bln from $75.8-76.1 bln (versus analysts' consensus estimate of $75.84 bln).
JNJ rose to $137.57 (+1.07%) in pre-market trading.
Enfoque del mercado
Material posted here is solely for information purposes and reliance on this may lead to losses. Past performances are not a reliable indicator of future results. Please read our full disclaimerAbrir cuenta demo y página personal